Survey on the Treatment of Hypertension in Patients With Type 2 Diabetes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1060 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-11-30

Study Completion Date

2009-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Multi-centre survey of type 2 diabetic patients who are currently on anti-hypertensive treatment. Data collection for each patient will take place at one visit. To observe the proportion of diabetic patients on antihypertensive treatment reaching the BP\<130/80 mmHg. To observe the proportion of diabetic patients on antihypertensive treatment reaching the BP\<130/80 mmHg by treatment groups. To observe the proportion of patients achieving a therapeutic glycemic response defined as HbA1c=\<7%. To observe the proportion of patients achieving fasting plasma glucose\<110 mg%. To identify factors for not achieving BP\<130/80 mmHg. To describe percentage of patients with positive proteinuria (including microalbuminuria) by treatment groups .

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

20 Years Results by HBP and DBP in Patients With Type 2 Diabetes Mellitus After Following-up

NCT02569151

Diabetes Mellitus

NOT_YET_RECRUITING

Precise Treatment of Prediabetes and Stage 1 Hypertension

NCT04529590

Diabetes

COMPLETED

Resistant Hypertension in Patients With Type-II-Diabetes Mellitus

NCT01056367

Resistant Hypertension NIDDM

COMPLETED

HbA1c Prediction Model in Patients With Type 2 Diabetes

NCT05824286

Diabetes Mellitus, Type 2

UNKNOWN NA

Blood Pressure Control for Type 2 Diabetes

NCT03477786

Type 2 Diabetes Mellitus Hypertension

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension Type 2 Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Provision of written informed consent
* Patient was diagnosed with type 2 diabetes
* Patient is on antihypertensive treatments for at least 3 months, with the same regimen for a minimum of 4 weeks prior to survey

Exclusion Criteria

* Patients are critically ill, had mental health problems or difficulty in communication
* Patients who are unwilling or unable to provide informed consent
* Involvement in the planning and conduct of the study (applies to both AstraZeneca staff or staff at the study site).

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No